Vanda Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell VNDA and other ETFs, options, and stocks.

About VNDA

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. 

CEO
Mihael Hristos Polymeropoulos
CEOMihael Hristos Polymeropoulos
Employees
368
Employees368
Headquarters
Washington, District of Columbia
HeadquartersWashington, District of Columbia
Founded
2002
Founded2002
Employees
368
Employees368

VNDA Key Statistics

Market cap
256.45M
Market cap256.45M
Price-Earnings ratio
-3.04
Price-Earnings ratio-3.04
Dividend yield
Dividend yield
Average volume
807.66K
Average volume807.66K
High today
$4.51
High today$4.51
Low today
$4.28
Low today$4.28
Open price
$4.36
Open price$4.36
Volume
1.12M
Volume1.12M
52 Week high
$5.70
52 Week high$5.70
52 Week low
$3.81
52 Week low$3.81

VNDA News

TipRanks 3d
Vanda Pharmaceuticals’ Earnings Call: Growth Amid Challenges

Vanda Pharmaceuticals ((VNDA)) has held its Q3 earnings call. Read on for the main highlights of the call. Elevate Your Investing Strategy: Take advantage of Ti...

TipRanks 4d
Vanda Pharmaceuticals Reports Strong Sales Growth and Pipeline Progress

Vanda Pharmaceuticals ( (VNDA) ) has released its Q3 earnings. Here is a breakdown of the information Vanda Pharmaceuticals presented to its investors. Elevate...

Seeking Alpha 4d
Vanda narrows 2025 revenue guidance to $210M-$230M amid Fanapt growth and strategic investments

Earnings Call Insights Vanda narrows 2025 revenue guidance to $210M-$230M amid Fanapt growth and strategic investments Oct. 29, 2025 10:17 PM ET Vanda Pharmaceu...

Vanda narrows 2025 revenue guidance to $210M-$230M amid Fanapt growth and strategic investments

More VNDA News

TipRanks 6d
Vanda Pharmaceuticals Advances with Promising Social Anxiety Disorder Treatment Study

Vanda Pharmaceuticals ((VNDA)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50%...

TipRanks 7d
Vanda Pharmaceuticals Completes Key Bioequivalence Study for Schizophrenia and Bipolar Disorder Treatment

Vanda Pharmaceuticals ((VNDA)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50%...

People also own

Based on the portfolios of people who own VNDA. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.